Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Liq-E S.A. De C.V.
WARNING LETTER
•Liq-E S.A. De C.V.•November 19, 2020

FDA WARNING_LETTER - Liq-E S.A. De C.V. - November 19, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On November 19, 2020, the FDA issued a Warning Letter to Liq-E S.A. de C.V., a registered human drug manufacturer in Mexico, following the detention and refusal of their Optimus Lubricants Instant Hand Sanitizer at the U.S. border. FDA testing revealed the product, labeled to contain 70% ethanol, actually contained an average of 51% ethanol and 18% methanol.

This constitutes adulteration under section 501(d)(2) of the FD&C Act due to the substitution of ethanol with toxic methanol, and under 501(a)(2)(B) for demonstrating a non-functioning quality assurance system. Methanol is dangerous, causing dermatitis, systemic toxicity, and potentially blindness or death.

The product is also an unapproved new drug under section 505(a) and misbranded under sections 502(j), (a), (e), (i), (x), and (ee) of the FD&C Act. Violations include: being dangerous to health (502(j)), false and misleading labeling regarding ethanol content and undeclared methanol (502(a)), failure to list methanol as an ingredient (502(e)), misleading container resembling a water bottle (502(i)), failure to disclose a domestic adverse event contact (502(x)), and non-

Company
Liq-E S.A. De C.V.
Inspection Date
November 19, 2020
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Francis Godwin (Director)
  • David Lennarz
Open in Dashboard

ID · f40b80d8-0b7c-41ac-a904-691b04836f90

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 351(d)(2)21.U.S.C. 355(a)21 U.S.C. 352(j)21 U.S.C. 352(a)21 U.S.C. 352(e)21 U.S.C. 352(i)21 U.S.C. 352(x)21 U.S.C. 352(ee)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.